GlobalResearch and clinical trials
Data on the first 74 patients published from an international study following the course of Leigh syndrome
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
People with Leigh syndrome are followed regularly at five centers, every 3-6 months. Data from the first 74 participants were analyzed. Participants' ages ranged from 0 to 50 years, with a mean of 10.7 years. The most common cause was the MT-ATP6 gene (22%). The selected measurement tools were found to be consistent with one another.
What does it mean for patients and families?
This is not a drug study. Knowing the natural course of the disease makes it easier to inform families and to set up drug trials in the future.
Source
Scientific paper: Interim analysis of an international multi-site prospective natural history study evaluating the clinical presentation and progression of Leigh syndrome spectrum disorders. Therapeutic Advances in Rare Disease, 2026. DOI: 10.1177/26330040261476231 · PubMed 42662191
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Leigh syndrome
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.